Cardiovascular and metabolic risk

Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
Kohjiro Ueki, Takayoshi Sasako, Masayuki Kato, Yukiko Okazaki, Sumie Okahata, Hisayuki Katsuyama, Mikiko Haraguchi, Ai Morita, Ken Ohashi, Kazuo Hara, Atsushi Morise, Kazuo Izumi, Yasuo Ohashi, Mitsuhiko Noda, Takashi Kadowaki, the J-DOIT3 Study Group

BMJ Open Diabetes Research and Care Jan 2016, 4 (1) e000123; DOI: 10.1136/bmjdrc-2015-000123
Indirect measure of visceral adiposity ‘A Body Shape Index’ (ABSI) is associated with arterial stiffness in patients with type 2 diabetes
Ryotaro Bouchi, Masahiro Asakawa, Norihiko Ohara, Yujiro Nakano, Takato Takeuchi, Masanori Murakami, Yuriko Sasahara, Mitsuyuki Numasawa, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa

BMJ Open Diabetes Research and Care Mar 2016, 4 (1) e000188; DOI: 10.1136/bmjdrc-2015-000188
Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
Marion C Devers, Stewart Campbell, David Simmons

BMJ Open Diabetes Research and Care Apr 2016, 4 (1) e000195; DOI: 10.1136/bmjdrc-2016-000195
Gender-related affecting factors of prediabetes on its 10-year outcome
Xiaomin Song, Miaoyan Qiu, Xuan'e Zhang, Haiyan Wang, Wenxin Tong, Liping Ju, Lei Gu, Siming Sun, Hongli Zhang, Weiqing Wang, Jingyan Tian

BMJ Open Diabetes Research and Care May 2016, 4 (1) e000169; DOI: 10.1136/bmjdrc-2015-000169
Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy
Mary T Korytkowski, Esra Karslioglu French, Maria Brooks, Dilhari DeAlmeida, Justin Kanter, Manuel Lombardero, Vasudev Magaji, Trevor Orchard, Linda Siminerio

BMJ Open Diabetes Research and Care May 2016, 4 (1) e000206; DOI: 10.1136/bmjdrc-2016-000206
PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
Giulia Buonaiuto, Valentina De Mori, Alessandra Braus, Annalisa Balini, Denise Berzi, Rita Carpinteri, Franco Forloni, Giancarla Meregalli, Gian Luca Ronco, Antonio C Bossi

BMJ Open Diabetes Research and Care Jul 2016, 4 (1) e000216; DOI: 10.1136/bmjdrc-2016-000216
Ethnic differences in serum lipids and lipoproteins in overweight/obese African-American and white American women with pre-diabetes: significance of NMR-derived lipoprotein particle concentrations and sizes
Trudy Gaillard, Kwame Osei

BMJ Open Diabetes Research and Care Jul 2016, 4 (1) e000246; DOI: 10.1136/bmjdrc-2016-000246
Hyperinsulinemia and sulfonylurea use are independently associated with left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus with suboptimal blood glucose control
Tomoaki Inoue, Yasutaka Maeda, Noriyuki Sonoda, Shuji Sasaki, Teppei Kabemura, Kunihisa Kobayashi, Toyoshi Inoguchi

BMJ Open Diabetes Research and Care Aug 2016, 4 (1) e000223; DOI: 10.1136/bmjdrc-2016-000223
Evaluation of vitamin D relationship with type 2 diabetes and systolic blood pressure
Shivananda Bijoor Nayak, Terry Gavaskar Ramnanansingh

BMJ Open Diabetes Research and Care Oct 2016, 4 (1) e000285; DOI: 10.1136/bmjdrc-2016-000285
Inclusion of walnut in the diets of adults at risk for type 2 diabetes and their dietary pattern changes: a randomized, controlled, cross-over trial
Valentine Yanchou Njike, Niloufarsadat Yarandi, Paul Petraro, Rockiy G Ayettey, Judith A Treu, David L Katz

BMJ Open Diabetes Research and Care Oct 2016, 4 (1) e000293; DOI: 10.1136/bmjdrc-2016-000293

Main menu

Cardiovascular and metabolic risk

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cardiovascular and metabolic risk

Pages